EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

INTELLIGENT INTRAOPERATIVE NEUROPATHOLOGY IN BRAIN TUMOR SURGERY: STIMULATED RAMAN HISTOLOGY, RAPID NANOPORE EPIGENOMICS, AND AI-GUIDED MARGIN ASSESSMENT

Ravshanov D.M.

Healthway · 22.07.2026 · 2 (4) · 260-278

DOI: 10.64411/x1kvfm62 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Healthway, online erschienen am 22.07.2026. Verfasst von Ravshanov D.M.. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractBackground. Intraoperative neuropathology is moving from morphology-only frozen-section consultation toward integrated optical, molecular, and artificial-intelligence workflows capable of informing surgery before closure. Stimulated Raman histology provides label-free microscopic images from fresh tissue, whereas rapid nanopore sequencing, microfluidic polymerase-chain-reaction systems, and foundation models can estimate tumor class, molecular subtype, and infiltration within minutes. Materials and methods. Prospective multicenter studies, translational investigations, diagnostic-accuracy cohorts, and platform-validation studies published through July 2026 were synthesized. Evidence was organized according to specimen acquisition, optical histology, machine- learning interpretation, rapid epigenomic or genetic profiling, margin assessment, turnaround time, diagnostic confidence, and clinical decision impact.

Results

Stimulated Raman histology combined with deep learning achieves near-real-time tumor classification and can detect diffuse-glioma infiltration more accurately than several conventional intraoperative adjuncts. FastGlioma produced infiltration scores within seconds in an international prospective cohort. Rapid-CNS2 generated methylation classification and copy-number information within a thirty-minute intraoperative window, while Sturgeon and MethyLYZR demonstrated classification from sparse nanopore methylation data. Hetairos extended routine hematoxylin-and-eosin analysis toward prediction of 102 methylation-associated central-nervous- system tumor subtypes. Nevertheless, low tumor purity, sampling error, rare entities, domain shift, overconfident predictions, and uncertain action thresholds remain limitations.

Conclusion

Intelligent intraoperative neuropathology should augment rather than replace neuropathology. The proposed SMART-PATH framework integrates sampling, multimodal acquisition, algorithmic confidence, rapid molecular testing, topographic mapping, pathology verification, actionable interpretation, and human oversight to support maximal safe resection and adequate biopsy.Keywords: stimulated Raman histology; artificial intelligence; brain tumor surgery; nanopore sequencing; DNA methylation; glioma infiltration; intraoperative diagnosis; digital neuropathology; molecular classification; surgical margin.

Zitieren

APA

D.M., R. (2026). INTELLIGENT INTRAOPERATIVE NEUROPATHOLOGY IN BRAIN TUMOR SURGERY: STIMULATED RAMAN HISTOLOGY, RAPID NANOPORE EPIGENOMICS, AND AI-GUIDED MARGIN ASSESSMENT. Healthway, 2(4), 260-278. https://doi.org/10.64411/x1kvfm62

Vancouver

D.M. R. INTELLIGENT INTRAOPERATIVE NEUROPATHOLOGY IN BRAIN TUMOR SURGERY: STIMULATED RAMAN HISTOLOGY, RAPID NANOPORE EPIGENOMICS, AND AI-GUIDED MARGIN ASSESSMENT. Healthway. 2026;2(4):260-278. doi:10.64411/x1kvfm62

BibTeX
@article{DM2026,
  author = {D.M., Ravshanov},
  title = {INTELLIGENT INTRAOPERATIVE NEUROPATHOLOGY IN BRAIN TUMOR SURGERY: STIMULATED RAMAN HISTOLOGY, RAPID NANOPORE EPIGENOMICS, AND AI-GUIDED MARGIN ASSESSMENT},
  journal = {Healthway},
  year = {2026},
  volume = {2},
  number = {4},
  pages = {260--278},
  doi = {10.64411/x1kvfm62}
}
Kostenlos starten →